Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The ITP-RITUX Cohort: An Observational Study on Rituximab Off-label Use for Immune ThrombocytoPenia.

NCT01101295 is registered in ClinicalTrials.gov with Henri Mondor University Hospital as lead sponsor.

NCT NCT01101295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01101295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The ITP-RITUX Cohort: An Observational Study on Rituximab Off-label Use for Immune ThrombocytoPenia.
Lead sponsor
Henri Mondor University Hospital
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2010
Completion date
April 30, 2017
Enrollment
250 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune thrombocytopenia, purpura, thrombocytopenic, idiopathic